便携式胸部X线摄影作为COVID-19疫情期间不良临床结局的排除性检查
研究在纽约市5个急诊科连续纳入2020年3月19日至4月23日疑似COVID-19的成人患者3245例,其中474例(14.6%)初始胸片阴性。初始胸片阴性者未来不良临床结局概率低,住院、机械通气、ARDS和死亡的阴性似然比分别为0.27(95%CI 0.23-0.31)、0.24(95%CI 0.16-0.37)、0.19(95%CI 0.09-0.40)和0.38(95%CI 0.29-0.51)。在年龄小于65岁且症状持续时间至少5天的955例患者亚组中,胸片阴性者无死亡,住院、机械通气和ARDS的阴性似然比分别为0.17(95%CI 0.12-0.25)、0.09(95%CI 0.02-0.36)和0.09(95%CI 0.01-0.64)。作者认为初始胸片是成人疑似COVID-19患者住院、机械通气、ARDS和死亡的有力排除性检查,在年轻成人、合并症少和症状持续时间长的患者中排除价值最高。
要点
- 在3245例疑似COVID-19成人中,初始胸片阴性者住院的阴性似然比为0.27(95%CI 0.23-0.31),机械通气为0.24(95%CI 0.16-0.37),ARDS为0.19(95%CI 0.09-0.40),死亡为0.38(95%CI 0.29-0.51)。
- 在年龄小于65岁且症状持续时间至少5天的955例亚组中,初始胸片阴性者无死亡,住院、机械通气和ARDS的阴性似然比分别为0.17(95%CI 0.12-0.25)、0.09(95%CI 0.02-0.36)和0.09(95%CI 0.01-0.64)。
- 初始胸片阴性对不良临床结局的排除价值在年轻成人、合并症少和症状持续时间长的患者中最高。
- 初始胸片阴性不能完全排除不良结局,临床决策仍需结合其他评估。
适用人群与场景
- 2020年3月19日至4月23日在纽约市5个急诊科连续就诊的疑似COVID-19成人患者。
- 亚组分析纳入年龄小于65岁且症状持续时间至少5天的患者。
研究设计与关键结果
- 研究类型为对连续病例的病历回顾,纳入3245例成人疑似COVID-19患者,其中474例(14.6%)初始胸片阴性。
- 初始胸片阴性者住院的阴性似然比为0.27(95%CI 0.23-0.31),机械通气为0.24(95%CI 0.16-0.37),ARDS为0.19(95%CI 0.09-0.40),死亡为0.38(95%CI 0.29-0.51)。
- 在年龄小于65岁且症状持续时间至少5天的955例患者亚组中,初始胸片阴性者无死亡,住院、机械通气和ARDS的阴性似然比分别为0.17(95%CI 0.12-0.25)、0.09(95%CI 0.02-0.36)和0.09(95%CI 0.01-0.64)。
证据类型、等级与局限
- 证据类型:对连续病例的病历回顾。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,在成人疑似COVID-19患者中,初始胸片是住院、机械通气、ARDS和死亡的有力排除性检查;其排除价值在年轻成人、合并症少和症状持续时间长的患者中最高。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Chest radiography (CXR) often is performed in the acute setting to help understand the extent of respiratory disease in patients with COVID-19, but a clearly defined role for negative chest radiograph results in assessing patients has not been described.
RESEARCH QUESTION: Is portable CXR an effective exclusionary test for future adverse clinical outcomes in patients suspected of having COVID-19?
STUDY DESIGN AND METHODS: Charts of consecutive patients suspected of having COVID-19 at five EDs in New York City between March 19, 2020, and April 23, 2020, were reviewed. Patients were categorized based on absence of findings on initial CXR. The primary outcomes were hospital admission, mechanical ventilation, ARDS, and mortality.
RESULTS: Three thousand two hundred forty-five adult patients, 474 (14.6%) with negative initial CXR results, were reviewed. Among all patients, negative initial CXR results were associated with a low probability of future adverse clinical outcomes, with negative likelihood ratios of 0.27 (95% CI, 0.23-0.31) for hospital admission, 0.24 (95% CI, 0.16-0.37) for mechanical ventilation, 0.19 (95% CI, 0.09-0.40) for ARDS, and 0.38 (95% CI, 0.29-0.51) for mortality. Among the subset of 955 patients younger than 65 years and with a duration of symptoms of at least 5 days, no patients with negative CXR results died, and the negative likelihood ratios were 0.17 (95% CI, 0.12-0.25) for hospital admission, 0.09 (95% CI, 0.02-0.36) for mechanical ventilation, and 0.09 (95% CI, 0.01-0.64) for ARDS.
INTERPRETATION: Initial CXR in adult patients suspected of having COVID-19 is a strong exclusionary test for hospital admission, mechanical ventilation, ARDS, and mortality. The value of CXR as an exclusionary test for adverse clinical outcomes is highest among young adults, patients with few comorbidities, and those with a prolonged duration of symptoms.
参考来源
- Pagano A, Finkelstein M, Overbey J, et al. Portable Chest Radiography as an Exclusionary Test for Adverse Clinical Outcomes During the COVID-19 Pandemic. Chest. 2021. PMID: 33516703. doi:10.1016/j.chest.2021.01.053
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。